Reed's (REED) Q2 2024 earnings summary

Executive summary

• Net sales grew 19% year-over-year to $11.9 million in Q2 2024, driven by strong demand, growth initiatives, and expanded product authorizations.

• Gross margin expanded to 32.3% from 25.1% year-over-year, with gross profit rising 53% to $3.8 million.

• Operating loss narrowed to $0.7 million ($0.16/share) from $1.7 million ($0.55/share) year-over-year, while modified EBITDA turned positive at $45,000 versus a $1.6 million loss.

• Delivery and handling costs fell 16% to $1.4 million (12% of net sales, $2.18/case), reflecting improved distribution efficiency.

• Management reaffirmed 2024 guidance for net sales growth, margin expansion, and positive operating cash flow.

Financial highlights

• Net sales: $11.9 million in Q2 2024, up from $10.0 million in Q2 2023.

• Gross profit: $3.8 million, gross margin: 32.3% (up 720 bps year-over-year).

• Delivery and handling expense: $1.4 million, 12% of net sales, $2.18/case, down from $1.7 million, 17%, $3.05/case.

• Operating loss: $0.7 million ($0.16/share) vs. $1.7 million ($0.55/share) year-over-year.

• Net loss: $3.2 million vs. $3.1 million year-over-year; loss per share: $0.77 vs. $0.99.

Outlook and guidance

• Reaffirmed 2024 targets: net sales growth, gross margin expansion, modified EBITDA profitability, and positive operating cash flow.

• Anticipates further margin improvements and cost savings in the second half of 2024.

• Guidance does not factor in potential new supply chain challenges or further inflation.

• The company is evaluating funding alternatives and may seek additional equity or debt financing.